Buy-and-Build Strategy

Buy-and-build returns stack three sources of value. (1) Multiple arbitrage: small targets trade at low multiples (5-7x) and the consolidated platform exits at a higher one (10-12x), so every add-on is repriced upward. (2) Synergies: shared back office, procurement scale, and cross-selling raise combined margins. (3) Organic growth: a larger, professionalized company grows faster and can win bigger contracts. The arbitrage lever is what distinguishes buy-and-build from a simple single-asset LBO — it manufactures multiple expansion rather than relying on the market to re-rate the asset.

The strategy needs a deep pool of small, acquirable targets, which is why it targets fragmented, low-tech-disruption service sectors: HVAC, dental and veterinary practices, insurance brokerage, IT-managed services, waste, landscaping, and accounting. These industries have hundreds of founder-owned businesses too small to IPO or attract strategic buyers, so they sell cheaply. The consolidation thesis: a national, professionally managed roll-up is worth more than the sum of its mom-and-pop parts because of scale economics and a more attractive risk profile to the next buyer.

Buy-and-build is operationally intense and fails in predictable ways. Integration risk: bolting on companies faster than you can integrate them creates a fragile federation, not a platform. Multiple-arbitrage decay: if competitors crowd the same roll-up, add-on prices rise and the arbitrage compresses. Leverage stacking: financing each deal with debt can push debt/EBITDA to dangerous levels. And exit risk: the next buyer pays the platform multiple only if the business is genuinely integrated with clean, consolidated financials — otherwise they discount it as a roll-up of unintegrated parts.